Sign in

CIK 0001831828

  • Large accelerated filer

Vera Therapeutics, Inc.

Sign in to watch
Ticker
VERA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812744449
Phone
+1 650-770-0077
Business address
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,334,142
in 2 filings, $1.3M under 10b5-1 plans

Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Fordyce Marshall −$1.3M PRESIDENT AND CEO sold 14% of stake
Date Insider Transaction Shares Price Value Owned after
2023-08-21 Lin Celia Chief Medical Officer Sale 10b5-1 −1,490 $16.65 $25K 11,010
2023-02-15 Lin Celia Chief Medical Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2022-08-19 Lin Celia Chief Medical Officer Grant or award +12,500 12,500
2022-02-16 Lin Celia Chief Medical Officer Grant or award · Stock Option (right to buy) +52,412 52,412
2021-05-13 Lin Celia Chief Medical Officer Grant or award · Stock Option (right to buy) +16,916 16,916

Page 1 of 1 · 5 trades